We are live on ! Find out more
ST

Sabal Trust Portfolio holdings

AUM $1.8B
1-Year Est. Return 8.75%
This Fund
S&P 500
This Quarter Est. Return
+4.38%
1 Year Est. Return
+8.75%
3 Year Est. Return
+18.39%
5 Year Est. Return
+89.81%
10 Year Est. Return
+162.48%
AUM
$702M
AUM Growth
-$5.13M
Cap. Flow
-$32.4M
Cap. Flow %
-4.62%
Top 10 Hldgs %
33.47%
Holding
113
New
6
Increased
48
Reduced
25
Closed
10

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$16.8M
2
POT
Potash Corp Of Saskatchewan
POT
+$11.7M
3
ENB icon
Enbridge
ENB
+$5.21M
4
STI
SunTrust Banks, Inc.
STI
+$1.22M
5
PAYX icon
Paychex
PAYX
+$896K

Top Sells

Rank Stock Value
1
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$22.6M
2
ABBV icon
AbbVie
ABBV
+$20.5M
3
T icon
AT&T
T
+$15M
4
IBM icon
IBM
IBM
+$10.6M
5
RYN icon
Rayonier
RYN
+$4.5M

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Healthcare 11.77%
3 Consumer Staples 11.48%
4 Industrials 11.27%
5 Financials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
1
Intel
INTC
$462B
$27.4M 3.9%
886,272
-119
-0% -$3.26K
CVX icon
2
Chevron
CVX
$378B
$26.3M 3.74%
201,182
+2,554
+1% +$318K
MSFT icon
3
Microsoft
MSFT
$2.89T
$25.6M 3.65%
613,924
+2,124
+0.3% +$86K
GE icon
4
GE Aerospace
GE
$375B
$24M 3.42%
190,555
+2,844
+2% +$362K
IGIB icon
5
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$23.6M 3.37%
428,792
-5,896
-1% -$323K
JNJ icon
6
Johnson & Johnson
JNJ
$641B
$22.5M 3.21%
215,337
+326
+0.2% +$33K
NVS icon
7
Novartis
NVS
$297B
$22.3M 3.17%
274,292
+2,331
+0.9% +$183K
UL icon
8
Unilever
UL
$132B
$21.9M 3.12%
430,072
+3,749
+0.9% +$188K
DD
9
DELISTED
Du Pont De Nemours E I
DD
$21M 2.99%
337,280
+4,050
+1% +$260K
SE
10
DELISTED
Spectra Energy Corp Wi
SE
$20.4M 2.9%
479,596
-2,462
-0.5% -$98.6K
WFC icon
11
Wells Fargo
WFC
$264B
$20.2M 2.88%
384,336
+6,030
+2% +$303K
MMM icon
12
3M
MMM
$91.9B
$19.3M 2.75%
160,907
+1,040
+0.7% +$122K
BLK icon
13
Blackrock
BLK
$165B
$19.2M 2.74%
60,153
+1,768
+3% +$542K
CSCO icon
14
Cisco
CSCO
$452B
$19.2M 2.73%
771,085
+12,361
+2% +$295K
BAX icon
15
Baxter International
BAX
$12.1B
$18.8M 2.68%
479,698
+5,320
+1% +$213K
MCD icon
16
McDonald's
MCD
$192B
$18.8M 2.68%
186,964
+5,793
+3% +$585K
DUK icon
17
Duke Energy
DUK
$100B
$18.6M 2.65%
250,984
+4,560
+2% +$328K
PEP icon
18
PepsiCo
PEP
$191B
$18.6M 2.65%
208,194
+2,799
+1% +$242K
TFC icon
19
Truist Financial
TFC
$63.7B
$18.5M 2.64%
469,187
+14,385
+3% +$552K
WELL icon
20
Welltower
WELL
$175B
$18.3M 2.61%
292,019
-4,039
-1% -$254K
VYM icon
21
Vanguard High Dividend Yield ETF
VYM
$81.3B
$17.7M 2.53%
267,436
-308
-0.1% -$19.9K
PAYX icon
22
Paychex
PAYX
$41.1B
$17.7M 2.52%
426,089
+21,801
+5% +$896K
GIS icon
23
General Mills
GIS
$19.5B
$17.7M 2.52%
336,509
+2,727
+0.8% +$145K
UPS icon
24
United Parcel Service
UPS
$96B
$17M 2.42%
165,376
+3,683
+2% +$370K
ENB icon
25
Enbridge
ENB
$121B
$16.6M 2.37%
350,327
+110,075
+46% +$5.21M

Similar funds

Sabal Trust's Q2 2014 Portfolio in Review

As of Q2 2014, Sabal Trust held 113 positions worth $702M, down 0.72% from $707M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Sabal Trust withdrew a net $32.4M in Q2 2014, closing 10 positions and reducing 25 holdings. Its most notable exit was Royal Dutch Shell PLC ADS Class B, an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Sabal Trust opened a new position in GSK worth $16.6M.

  • Sabal Trust's largest Q2 2014 buy was GSK: 248,746 shares worth $16.6M.
  • Sabal Trust added most to Enbridge in Q2 2014, an estimated $5.21M increase.
  • Sabal Trust's biggest Q2 2014 reduction was IBM, cutting an estimated $10.6M.
  • Sabal Trust fully exited Royal Dutch Shell PLC ADS Class B in Q2 2014, selling an estimated $22.6M.
  • Sabal Trust's ten largest holdings make up 33% of its $702M portfolio in Q2 2014.
  • Sabal Trust opened 6 new positions and closed 10 in Q2 2014.
  • Sabal Trust's portfolio value fell 0.72% quarter-over-quarter to $702M.

Based on Sabal Trust's 13F filing for Q2 2014, filed 25 Jul 2014.